SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer

Breast Cancer Research and Treatment

Volumn 129, Issue 3, 2011, Pages 737-746

  Clausen, Kathryn A ^a   Blish, Kimberly R ^a   Birse, Charles E ^b   Triplette, Matthew A ^a   Kute, Timothy E ^a   Russell, Gregory B ^a   D'Agostino Jr , Ralph B ^a   Miller, Lance D ^a   Torti, Frank M ^a   Torti, Suzy V ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CELERA   (United States)

Author keywords

Beta catenin; Bone morphogenetic protein (BMP); Breast cancer; Sclerostin domain containing 1 (SOSTDC1); Wingless int (Wnt); Wise

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA; OSTEOGENIC PROTEIN 1; RECOMBINANT PROTEIN; SCLEROSTIN DOMAIN CONTAINING 1 PROTEIN; SMAD PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WNT3A PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TISSUE LEVEL; TISSUE MICROARRAY;

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 7; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; PHOSPHORYLATION; PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS; WNT3A PROTEIN;

EID: 80052604376     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1261-9     Document Type: Article

References (50)

1. American cancer society (2010) Cancer facts and figures 2010. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/ cancer-facts-and-figures-2010
2. Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MR, Stearns V, Winer EP, Somerfield MR, Griggs JJ (2010) American society of clinical oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol. doi: 10.1200/JCO.2009.26.3756
3. Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M (2010) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol. doi: 10.1093/annonc/mdq345
4. Ashok M, Griffin P, Halpern M (2010) Impact of clinical and non-clinical factors on the choice of her2 test for breast cancer. Cancer Invest. doi: 10.3109/07357907.2010.496753
5. V Bolos M Blanco V Medina G Aparicio S Diaz-Prado E Grande 2009 Notch signalling in cancer stem cells Clin Transl Oncol 11 1 11 19 19155199 10.1007/s12094-009-0305-2 1:STN:280:DC%2BD1M%2Fot1Omsg%3D%3D
6. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 10.1016/S0092-8674(00)81683-9 1:CAS:528:DC%2BD3cXks1CktA%3D%3D (Pubitemid 30046295)
7. CY Logan R Nusse 2004 The wnt signaling pathway in development and disease Annu Rev Cell Dev Biol 20 781 810 10.1146/annurev.cellbio.20.010403. 113126 15473860 10.1146/annurev.cellbio.20.010403.113126 1:CAS:528: DC%2BD2cXhtVejsr7I (Pubitemid 39488658)
8. LL Rubin FJ de Sauvage 2006 Targeting the hedgehog pathway in cancer Nat Rev Drug Discov 5 12 1026 1033 10.1038/nrd2086 17139287 10.1038/nrd2086 1:CAS:528:DC%2BD28Xht1Kju7vI (Pubitemid 44835129)
9. SJ Zardawi SA O'Toole RL Sutherland EA Musgrove 2009 Dysregulation of hedgehog, wnt and notch signalling pathways in breast cancer Histol Histopathol 24 3 385 398 19130408 1:CAS:528:DC%2BD1MXjtVyks7c%3D
10. O Avsian-Kretchmer AJ Hsueh 2004 Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists Mol Endocrinol 18 1 1 12 10.1210/me.2003-0227 14525956 10.1210/me.2003-0227 1:CAS:528:DC%2BD2cXjsVCjtg%3D%3D (Pubitemid 38073149)
11. N Itasaki CM Jones S Mercurio A Rowe PM Domingos JC Smith R Krumlauf 2003 Wise, a context-dependent activator and inhibitor of wnt signalling Development 130 18 4295 4305 12900447 10.1242/dev.00674 1:CAS:528:DC%2BD3sXnvVWnt7k%3D (Pubitemid 37185319)
12. Y Kassai P Munne Y Hotta E Penttila K Kavanagh N Ohbayashi S Takada I Thesleff J Jernvall N Itoh 2005 Regulation of mammalian tooth cusp patterning by ectodin Science 309 5743 2067 2070 10.1126/science.1116848 16179481 10.1126/science.1116848 1:CAS:528:DC%2BD2MXhtVWntLrL (Pubitemid 41362327)
13. GM Beaudoin 3rd JM Sisk PA Coulombe CC Thompson 2005 Hairless triggers reactivation of hair growth by promoting wnt signaling Proc Natl Acad Sci USA 102 41 14653 14658 10.1073/pnas.0507609102 16195376 10.1073/pnas.0507609102 1:CAS:528:DC%2BD2MXhtFKjsb7M (Pubitemid 41457111)
14. DG Simmons TG Kennedy 2002 Uterine sensitization-associated gene-1: a novel gene induced within the rat endometrium at the time of uterine receptivity/sensitization for the decidual cell reaction Biol Reprod 67 5 1638 1645 12390898 10.1095/biolreprod.102.006858 1:CAS:528:DC%2BD38Xot1Kjsbw%3D (Pubitemid 35204942)
15. M Yanagita T Okuda S Endo M Tanaka K Takahashi F Sugiyama S Kunita S Takahashi A Fukatsu M Yanagisawa T Kita T Sakurai 2006 Uterine sensitization-associated gene-1 (usag-1), a novel bmp antagonist expressed in the kidney, accelerates tubular injury J Clin Invest 116 1 70 79 10.1172/JCI25445 16341262 10.1172/JCI25445 1:CAS:528:DC%2BD28XjslOitQ%3D%3D (Pubitemid 43121792)
16. KR Blish W Wang MC Willingham W Du CE Birse SR Krishnan JC Brown GA Hawkins AJ Garvin RB D'Agostino Jr FM Torti SV Torti 2008 A human bone morphogenetic protein antagonist is down-regulated in renal cancer Mol Biol Cell 19 2 457 464 10.1091/mbc.E07-05-0433 18032587 10.1091/mbc.E07-05-0433 1:CAS:528:DC%2BD1cXlslentLw%3D (Pubitemid 351272135)
17. J Ohshima M Haruta Y Arai F Kasai Y Fujiwara T Ariga H Okita M Fukuzawa J Hata H Horie Y Kaneko 2009 Two candidate tumor suppressor genes, meox2 and sostdc1, identified in a 7p21 homozygous deletion region in a wilms tumor Genes Chromosomes Cancer 48 12 1037 1050 10.1002/gcc.20705 19760604 10.1002/gcc.20705 1:CAS:528:DC%2BD1MXht1KrtbrE
18. J Laurikkala Y Kassai L Pakkasjarvi I Thesleff N Itoh 2003 Identification of a secreted bmp antagonist, ectodin, integrating bmp, fgf, and shh signals from the tooth enamel knot Dev Biol 264 1 91 105 14623234 10.1016/j.ydbio.2003. 08.011 1:CAS:528:DC%2BD3sXovVeiu7Y%3D (Pubitemid 37393449)
19. W Balemans N Patel M Ebeling E Van Hul W Wuyts C Lacza M Dioszegi FG Dikkers P Hildering PJ Willems JB Verheij K Lindpaintner B Vickery D Foernzler W Van Hul 2002 Identification of a 52 kb deletion downstream of the sost gene in patients with van buchem disease J Med Genet 39 2 91 97 11836356 10.1136/jmg.39.2.91 1:CAS:528:DC%2BD38XitV2itbo%3D (Pubitemid 34146376)
20. BB Koenig JS Cook DH Wolsing J Ting JP Tiesman PE Correa CA Olson AL Pecquet F Ventura RA Grant, et al. 1994 Characterization and cloning of a receptor for bmp-2 and bmp-4 from nih 3t3 cells Mol Cell Biol 14 9 5961 5974 8065329 1:CAS:528:DyaK2cXmt1aiu7Y%3D (Pubitemid 24264425)
21. P ten Dijke H Yamashita TK Sampath AH Reddi M Estevez DL Riddle H Ichijo CH Heldin K Miyazono 1994 Identification of type i receptors for osteogenic protein-1 and bone morphogenetic protein-4 J Biol Chem 269 25 16985 16988 8006002 1:CAS:528:DyaK2cXltVSmurc%3D (Pubitemid 24204009)
22. R Derynck Y Zhang XH Feng 1998 Smads: transcriptional activators of tgf-beta responses Cell 95 6 737 740 9865691 10.1016/S0092-8674(00)81696-7 1:CAS:528:DyaK1MXivVGm (Pubitemid 29014453)
23. K Miyazawa M Shinozaki T Hara T Furuya K Miyazono 2002 Two major smad pathways in tgf-beta superfamily signalling Genes Cells 7 12 1191 1204 12485160 10.1046/j.1365-2443.2002.00599.x 1:CAS:528:DC%2BD3sXhtV2htg%3D%3D (Pubitemid 36024597)
24. M Yanagita M Oka T Watabe H Iguchi A Niida S Takahashi T Akiyama K Miyazono M Yanagisawa T Sakurai 2004 Usag-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney Biochem Biophys Res Commun 316 2 490 500 10.1016/j.bbrc.2004.02.075 15020244 10.1016/j.bbrc.2004.02.075 1:CAS:528:DC%2BD2cXitFKhurY%3D (Pubitemid 38338618)
25. H Clevers 2006 Wnt/beta-catenin signaling in development and disease Cell 127 3 469 480 10.1016/j.cell.2006.10.018 17081971 10.1016/j.cell.2006.10.018 1:CAS:528:DC%2BD28Xht1WhtbbN (Pubitemid 44647433)
26. TC He AB Sparks C Rago H Hermeking L Zawel LT da Costa PJ Morin B Vogelstein KW Kinzler 1998 Identification of c-myc as a target of the apc pathway Science 281 5382 1509 1512 9727977 10.1126/science.281.5382.1509 1:CAS:528:DyaK1cXlvFGntr0%3D (Pubitemid 28425575)
27. O Tetsu F McCormick 1999 Beta-catenin regulates expression of cyclin d1 in colon carcinoma cells Nature 398 6726 422 426 10.1038/18884 10201372 10.1038/18884 1:CAS:528:DyaK1MXisFGksrY%3D (Pubitemid 29180374)
28. M Shtutman J Zhurinsky I Simcha C Albanese M D'Amico R Pestell A Ben-Ze'ev 1999 The cyclin d1 gene is a target of the beta-catenin/lef-1 pathway Proc Natl Acad Sci USA 96 10 5522 5527 10318916 10.1073/pnas.96.10.5522 1:CAS:528:DyaK1MXjtFCnsbc%3D (Pubitemid 29234650)
29. S Guidato N Itasaki 2007 Wise retained in the endoplasmic reticulum inhibits wnt signaling by reducing cell surface lrp6 Dev Biol 310 2 250 263 10.1016/j.ydbio.2007.07.033 17765217 10.1016/j.ydbio.2007.07.033 1:CAS:528:DC%2BD2sXhtFSksr3J (Pubitemid 47483677)
30. EL Alarmo T Kuukasjarvi R Karhu A Kallioniemi 2007 A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of bmp4 and bmp7 Breast Cancer Res Treat 103 2 239 246 10.1007/s10549-006-9362-1 17004110 10.1007/s10549-006-9362-1 1:CAS:528:DC%2BD2sXltlaqtrs%3D (Pubitemid 46789146)
31. SF Arnold E Tims BE McGrath 1999 Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of bmp2 Cytokine 11 12 1031 1037 10.1006/cyto.1999.0508 10623428 10.1006/cyto.1999.0508 1:CAS:528:DC%2BD3cXht1CjtQ%3D%3D (Pubitemid 30045342)
32. JH Clement M Raida J Sanger R Bicknell J Liu A Naumann A Geyer A Waldau P Hortschansky A Schmidt K Hoffken S Wolft AL Harris 2005 Bone morphogenetic protein 2 (bmp-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells Int J Oncol 27 2 401 407 16010421 1:CAS:528:DC%2BD2MXnsl2rtLc%3D
33. EL Alarmo J Rauta P Kauraniemi R Karhu T Kuukasjarvi A Kallioniemi 2006 Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer Genes Chromosomes Cancer 45 4 411 419 10.1002/gcc.20307 16419056 10.1002/gcc.20307 1:CAS:528:DC%2BD28XitF2mt7g%3D (Pubitemid 43346773)
34. LR Howe AM Brown 2004 Wnt signaling and breast cancer Cancer Biol Ther 3 1 36 41 14739782 10.4161/cbt.3.1.561 1:CAS:528:DC%2BD2cXjsVGiurs%3D
35. AM Brown 2001 Wnt signaling in breast cancer: have we come full circle? Breast Cancer Res 3 6 351 355 11737884 10.1186/bcr321 1:CAS:528: DC%2BD38Xjs1amsg%3D%3D (Pubitemid 34196359)
36. SY Lin W Xia JC Wang KY Kwong B Spohn Y Wen RG Pestell MC Hung 2000 Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin d1 expression and cancer progression Proc Natl Acad Sci USA 97 8 4262 4266 10.1073/pnas.060025397 10759547 10.1073/pnas.060025397 1:CAS:528: DC%2BD3cXislSnsr4%3D (Pubitemid 30226121)
37. LD Miller J Smeds J George VB Vega L Vergara A Ploner Y Pawitan P Hall S Klaar ET Liu J Bergh 2005 An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc Natl Acad Sci USA 102 38 13550 13555 10.1073/pnas.0506230102 16141321 10.1073/pnas.0506230102 1:CAS:528:DC%2BD2MXhtVygtr7I (Pubitemid 41420886)
38. AV Ivshina J George O Senko B Mow TC Putti J Smeds T Lindahl Y Pawitan P Hall H Nordgren JE Wong ET Liu J Bergh VA Kuznetsov LD Miller 2006 Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer Cancer Res 66 21 10292 10301 10.1158/0008-5472.CAN-05-4414 17079448 10.1158/0008-5472.CAN-05-4414 1:CAS:528:DC%2BD28XhtFGjsrjM (Pubitemid 44799747)
39. S Loi B Haibe-Kains C Desmedt F Lallemand AM Tutt C Gillet P Ellis A Harris J Bergh JA Foekens JG Klijn D Larsimont M Buyse G Bontempi M Delorenzi MJ Piccart C Sotiriou 2007 Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade J Clin Oncol 25 10 1239 1246 10.1200/JCO.2006.07.1522 17401012 10.1200/JCO.2006.07.1522 1:CAS:528:DC%2BD2sXkvFyms7w%3D (Pubitemid 46640570)
40. Y Pawitan J Bjohle L Amler AL Borg S Egyhazi P Hall X Han L Holmberg F Huang S Klaar ET Liu L Miller H Nordgren A Ploner K Sandelin PM Shaw J Smeds L Skoog S Wedren J Bergh 2005 Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Breast Cancer Res 7 6 R953 R964 10.1186/bcr1325 16280042 10.1186/bcr1325 1:CAS:528:DC%2BD2MXht1WmsrjM
41. S Loi B Haibe-Kains C Desmedt P Wirapati F Lallemand AM Tutt C Gillet P Ellis K Ryder JF Reid MG Daidone MA Pierotti EM Berns MP Jansen JA Foekens M Delorenzi G Bontempi MJ Piccart C Sotiriou 2008 Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen BMC Genomics 9 239 10.1186/1471-2164-9-239 18498629 10.1186/1471-2164-9-239 (Pubitemid 351804039)
42. BL Stackhouse H Williams P Berry G Russell P Thompson JL Winter T Kute 2005 Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer Breast Cancer Res Treat 93 3 247 253 10.1007/s10549-005-5158-y 16228617 10.1007/s10549-005-5158-y 1:CAS:528:DC%2BD2MXhtFWmtrnF (Pubitemid 41441294)
43. HA Lehr DA Mankoff D Corwin G Santeusanio AM Gown 1997 Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer J Histochem Cytochem 45 11 1559 1565 9358857 10.1177/002215549704501112 1:CAS:528:DyaK2sXntVSqtb0%3D (Pubitemid 27465476)
44. KB Lintern S Guidato A Rowe JW Saldanha N Itasaki 2009 Characterization of wise protein and its molecular mechanism to interact with both wnt and bmp signals J Biol Chem 284 34 23159 23168 10.1074/jbc.M109.025478 19553665 10.1074/jbc.M109.025478 1:CAS:528:DC%2BD1MXpvFKiu7Y%3D
45. B Elenbaas L Spirio F Koerner MD Fleming DB Zimonjic JL Donaher NC Popescu WC Hahn RA Weinberg 2001 Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells Genes Dev 15 1 50 65 11156605 10.1101/gad.828901 1:CAS:528:DC%2BD3MXhvVKhu78%3D (Pubitemid 32060682)
46. WM Knosp C Saneyoshi S Shou HP Bachinger HS Stadler 2007 Elucidation, quantitative refinement, and in vivo utilization of the hoxa13 DNA binding site J Biol Chem 282 9 6843 6853 10.1074/jbc.M610775200 17200107 10.1074/jbc. M610775200 1:CAS:528:DC%2BD2sXitVCitLc%3D (Pubitemid 47100910)
47. A Yamamoto T Nagano S Takehara M Hibi S Aizawa 2005 Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, wnt and fgf Cell 120 2 223 235 10.1016/j.cell.2004.11.051 15680328 10.1016/j.cell.2004.11.051 1:CAS:528:DC%2BD2MXht1emur0%3D (Pubitemid 40174765)
48. M Verras I Papandreou AL Lim NC Denko 2008 Tumor hypoxia blocks wnt processing and secretion through the induction of endoplasmic reticulum stress Mol Cell Biol 28 23 7212 7224 10.1128/MCB.00947-08 18824543 10.1128/MCB.00947-08 1:CAS:528:DC%2BD1cXhsVCjsb3K
49. L Ye JM Lewis-Russell HG Kyanaston WG Jiang 2007 Bone morphogenetic proteins and their receptor signaling in prostate cancer Histol Histopathol 22 10 1129 1147 17616940 1:CAS:528:DC%2BD2sXhtlaks7nO (Pubitemid 47470307)
50. N Ghosh-Choudhury G Ghosh-Choudhury A Celeste PM Ghosh M Moyer SL Abboud J Kreisberg 2000 Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated mcf-7 human breast cancer cells Biochim Biophys Acta 1497 2 186 196 10903423 10.1016/S0167-4889(00)00060-4 1:CAS:528:DC%2BD3cXkvFSgurk%3D (Pubitemid 30618830)